To gain insight into the role of cell surface glycosaminoglycans (GAG) in dengue virus (DEN) cell tropism and virulence, DEN-2 mouse brain-adapted vaccine candidate, neurovirulent prototype strain (NGC) and low-passage strain, PUO-218, were passaged in BHK-21 and SW13 cells to isolate variants with high affinity for GAG. Sequence comparisons of parent and passage variants revealed five GAG-binding determinants, which all cluster in a surface-exposed region in domain II of the three-dimensional structure of the DEN envelope protein. Using an infectious cDNA clone of NGC and an NGC/PUO-218 prM-E chimeric clone, it was demonstrated that the GAG-binding determinants augment the specific infectivity for BHK-21 and/or SW13 cells by 10-to 170-fold and in some cases marginally reduce that for Vero cells. This altered cell tropism was due to a greater dependence of the variants on cell surface GAG for attachment/entry, given their increased susceptibility to heparin inhibition. The effect of the GAG-binding determinants on virulence was examined in mice deficient in alpha/beta/gamma interferon responses. High GAG affinity strongly correlated with low neuroinvasiveness due to rapid virus clearance from the blood. It was speculated that this mechanism accounts for the attenuation in primates of some DEN vaccine candidates. Interestingly, the GAG-binding variants did not display marked attenuation of neurovirulence and the opposing effect of enhanced neurovirulence was associated with one determinant (Lys 126 ) already present in mouse brain-adapted NGC. This discrepancy of attenuated neuroinvasiveness and augmented neurovirulence may be reconciled by the existence of different mechanisms of virus dissemination in the brain and in extraneural tissues.
INTRODUCTION
Glycosaminoglycans (GAG) are complex, linear, sulfated polysaccharides found abundantly on cellular surfaces and in the extracellular matrix of most multicellular organisms (reviewed by Bernfield et al., 1999; Esko & Selleck, 2002) . They display an enormous structural diversity and have a critical role in a wide range of biological processes (see Bernfield et al., 1999; Esko & Selleck, 2002; Handel et al., 2005; Lindahl et al., 1998; Perrimon & Bernfield, 2000; Sasisekharan et al., 2002) . Numerous viruses utilize GAG for attachment to host cells, although subsequent infection may require virus association with additional cellular receptors (reviewed by Rostand & Esko, 1997; Spillmann, 2001) . Virus binding to GAG involves primarily the electrostatic interaction of clusters of basic amino acids on the virion surface with negatively charged sulfate groups on the polysaccharide. The crystal structure of a foot-and-mouth disease virus-heparin complex (Fry et al., 1999) and computer simulation of heparin docking to the adeno-associated virus capsid protein (Kern et al., 2003) suggest that GAG binds along shallow depressions on the virions in which the GAG-binding determinants are situated, whilst a cryoelectron microscopy investigation on heparin association with a GAG-binding mutant of Ross River virus showed that binding was mediated by the distal end of the E2 spike proteins (Zhang et al., 2005) .
Virus affinity for GAG is a determinant of cell tropism, and the acquisition of additional positive charge at GAGbinding sites is a common adaptation of viruses grown in cell culture (reviewed by Spillmann, 2001) . However, our studies on the encephalitic flaviviruses, Murray Valley encephalitis virus (MVE), Japanese encephalitis virus (JEV) and West Nile virus (WNV) (Lee et al., 2004; Lee & Lobigs, 2002) , and the work of others on Foot-and-mouth disease virus (Sa-Carvalho et al., 1997), Sindbis virus (Byrnes & Griffin, 2000) , Venezuelan equine encephalitis virus (Bernard et al., 2000) and Classical swine fever virus (Van Gennip et al., 2004) have demonstrated that the increased infectivity in cell culture of host cell-adapted viruses is a disadvantage for virus growth in vivo, because the high GAG-binding affinity prevents efficient virus spread through the circulation. The loss of virulence due to high GAG-binding affinity raises the question as to whether, and to what extent, this mechanism also accounts for the virulence attenuation of live vaccines or vaccine candidates. In case of a live JEV vaccine widely used in China (strain SA14-14-2), high GAG-binding affinity contributes, at least in part, to its attenuated virulence phenotype (Lee & Lobigs, 2002) .
The interaction of Dengue virus (DEN) with GAG was first shown by Chen et al. (1997) who also identified two putative GAG-binding regions, one spanning domains I and III and a second on domain III on the crystal structure of the viral envelope (E) protein (Modis et al., 2003; Rey et al., 1995) . DEN is a mosquito-borne flavivirus causing a high incidence of human disease, ranging from fever to life-threatening haemorrhagic fever and shock, in tropical and subtropical countries (reviewed by Burke & Monath, 2001) . Others have confirmed the putative involvement of cell surface GAG in attachment to and infection of host cells by DEN for each of the four serotypes (DEN-1-DEN-4) (Germi et al., 2002; Hilgard & Stockert, 2000; Hung et al., 1999 Hung et al., , 2004 Lee et al., 2006; Lin et al., 2002; Thullier et al., 2001 ) and the antiviral activity against DEN of heparan sulfate mimetics has been shown in vitro and in vivo (Lee et al., 2006; Marks et al., 2001; Ono et al., 2003; Talarico et al., 2005) . The molecular GAGbinding determinants of DEN and the role of GAG-binding affinity in DEN virulence have, so far, not been defined and these topics have been investigated in this study.
METHODS
Cells and viruses. African green monkey kidney (Vero), baby hamster kidney (BHK-21), human adenocarcinoma (SW13) and Aedes albopictus (C6/36) mosquito cells were grown as described previously (Lee et al., 2004 (Lee et al., , 2006 . Working stocks of DEN-2 strains NGC, isolated in 1944, passaged 24 times in suckling mouse brain, four times in equine kidney (EK) cells and twice in C6/36 cells (Gruenberg et al., 1988) , and PUO-218, isolated from Thailand in 1988 from patient sera, passaged once in Toxorhynchites splendens mosquitoes, once in monkey kidney (LLC-MK) cells and twice in C6/36 cells, were C6/36 cell supernatants.
Serial passage of DEN-2 viruses in SW13 and BHK-21 cells.
SW13 or BHK-21 cell monolayers in 60 mm dishes (1610  6 and  5610 5 cells, respectively) were infected with DEN-2 NGC or PUO-218 strains at an m.o.i. of 0?1 Vero p.f.u., and supernatants were collected and supplemented with HEPES (pH 8?0; 20 mM final concentration) at 5 days post-infection (p.i.). Four subsequent passages were performed for each passage series using 0?2 ml of the corresponding supernatants and harvesting culture medium following appearance of cytopathic effects (cpe) or at 5 days p.i. After five passages, plaque-purified stocks were prepared as described previously (Lee et al., 2004) by amplification in BHK-21 cells.
Sequence analysis. Total cellular RNA from infected BHK-21 cells (for passage variants) or infected Vero cells (for parent viruses) was extracted using Trizol (GibcoBRL) as described previously (Lee et al., 2004) . RT-PCR was performed as described previously (Lee & Lobigs, 2002) using random hexamers in the reverse transcription (RT) step and the DEN-2-specific primer pair, p2425: 59-CAGCTC-ACAACGCAACCACT-39 and p400: 59-GCAGGCATGATCATTATG-CT-39, for PCR. PCR-amplified cDNA fragments were gel-purified and used in cycle sequencing with ABI Big-Dye v3 chemistry (Applied Biosys). Additional primers for sequencing of DEN-2 prM and E genes were P787: 59-TGGAAACATGCCCAGAGAAT-39, P1567: P59-CAATGGTTCCTAGACCTGCC-39 and P1669: 59-ACAACATCCTG-TTTCTTCGC-39.
Plasmids. Plasmid pDVWS601 contains the full-length cDNA of the DEN-2 NGC genome flanked by a T7 RNA polymerase promoter at the 59 end and an XbaI restriction site at the 39 end (Gualano et al., 1998) . Viral RNA from parental virus and passaged variants of DEN-2 PUO-218 and NGC strains was reverse-transcribed as described above and cDNA encoding the E protein was amplified by PCR using primers P787 and P2863: 59-TTCCAGCGAATTCCAA-GCTCT-39. To introduce changes at E protein residue 227 or 249, a 1 kb region flanked by SphI and NheI sites in pDVWS601 was replaced with SphI-NheI fragments derived from RT-PCR-amplified cDNA of SW13 cell-passaged or BHK-21 cell-passaged NGC, respectively. To replace the DEN-2 strain NGC prM and E protein genes in pDVWS601 with those from PUO-218, two fragments from pDVWS601, a 1?5 kb fragment flanked by NotI (upstream of the T7 RNA polymerase promoter) and HindIII (nt 1547) sites and a 1?3 kb fragment flanked by SphI (nt 1380) and PstI (nt 2731) sites were subcloned into vector plasmids pACdel, in which the BamHI-BanI fragment from pACYC174 (New England Biolabs) had been replaced with the polylinkers from pBluescriptKS+ (Stratagene) or pGEM-5Zf (Promega), respectively, to generate plasmids pACprME59 and pGEME39. Regions flanked by BclI (nt 407) and SphI (nt 1380) or by SphI and SpeI (nt 2370) in pACprME59 and pGEME39, respectively, were replaced with the corresponding cDNA fragments derived from PUO-218 viral RNA, or those derived from SW13 or BHK-21 cell-passaged PUO-218 to introduce the PUO-218 prM and E genes with or without coding changes to the E aa 120, 124 or 202 into the DEN-2 NGC genome. Full-length DEN-2 plasmids were generated by ligating three DNA fragments: a NotI-SphI fragment from pACprME59 derivatives, an SphI-NheI fragment from pGEME39 derivatives and a NotI-NheI fragment from the pDVWS601 plasmid. All plasmid constructs were verified by sequencing the entire prM and E protein genes.
RNA transcription and electroporation of BHK-21 cells.
Plasmids containing the full-length DEN-2 cDNAs were digested with XbaI, transcribed using T7 RNA polymerase and full-length RNA transcripts electroporated into BHK-21 cells as described previously (Lee & Lobigs, 2000) with the following modifications. For determination of electroporation efficiency, 200, 20 or 2 ml of electroporated cells (25 ml at 4610 5 cells ml
21
) were plated onto Vero cell monolayers in six-well trays (3?5610 5 cells per well; Nunc), incubated for 1 h and agar overlay medium (M199 medium plus 1 % agar and 2 % fetal calf serum) added. Neutral red (0?02 %) was added at 4 days p.i. and plaques counted after overnight incubation.
Heparin-Sepharose binding and heparin inhibition assays.
Binding of DEN-2 viruses (10 5 -10 6 p.f.u.) to heparin-Sepharose beads was assayed as described previously (Lee et al., 2004) . Inhibition by heparin of infectivity of DEN-2 viruses was examined by incubating virus (1-5610 6 p.f.u.) with heparin (0?2, 2, 20 or 200 mg ml
) for 15 min prior to its addition to BHK-21 cell monolayers (4610 5 cells per well in six-well plates) treated with similar concentrations of heparin. Mock-treated controls were performed by preincubation of the same amount of virus in Hanks' balanced salts solution (HBSS)-BSA in the absence of heparin. Cells were harvested by trypsinization at 21 h p.i. and the percentage of infected cells determined by flow-cytometry as described previously (Lee et al., 2006) . Specific infectivity determination. Specific infectivity of DEN-2 virus particles was determined as described previously (Lee et al., 2004) with the following modifications. Infectivity of virus, released from infected BHK-21 cells over a 2 h incubation period, on BHK-21, Vero and SW13 cells was determined by TCID 50 assay in 96-well trays using NS1 protein-specific mAb 4G4 for the detection of virusinfected cell monolayers by ELISA (Licon Luna et al., 2002) . Viral RNA in the infected culture supernatant (100 ml) was extracted for quantification of virion RNA content by competitive RT-PCR. The internal standard was a DEN-2 competitor RNA (DEN2-cRNA). This was generated by in vitro transcription using T7 RNA polymerase (Promega) of a recombinant pBKS+ (Invitrogen) plasmid containing the DEN-2 NGC genome from nt 400 to 2444 (Gruenberg et al., 1988) , but with an insertion of a~100 bp DNA fragment from the polylinker region of pBluescriptKS+ at the MunI site in the E protein gene (nt 2092). Plasmid DNA linearized at the ApaI site at the 39 end of the DEN-2 insert was used as template for T7 RNA polymerase and a trace amount of [ 3 H]UTP was added for determination of the yield of DEN-2-cRNA transcript (Sambrook et al., 1989) . RT of mixtures of viral RNA and serially diluted DEN-2-cRNA was performed using the antisense primer P2425, followed by PCR using primer P2425 and the sense primer P1567 as described previously (Lee et al., 2004) . PCR products were electrophoresed in 1?3 % agarose gels. The concentrations of DEN2-cRNA spiked into PCR reactions in the presence of a constant amount of virion RNA at which two PCR product DNA bands of 878 and 978 bp of similar intensity were visible allowed estimation of the concentration of the virion RNA.
Mouse experiments. Six-week-old alpha and gamma interferon receptor double knockout (IFN-a/c-R 2/2 ) mice (van den Broek et al., 1995) were used for virulence assays. Virus inocula (100 ml), diluted in HBSS-BSA, were injected by the intraperitoneal (i.p.) or intravenous (i.v.) routes. For intracerebral (i.c.) inoculation, the virus inoculum (30 ml) was given to mice anaesthetized with ketamine/xylazol using a 26G needle. Mortality and morbidity were monitored over a period of 28 days. Clearance of virus from the circulation was assayed as described previously (Lee et al., 2004) .
RESULTS
Adaptation of DEN-2 NGC and PUO-218 strains to grow in SW13 and BHK-21 cells
To generate host cell-adapted variants of DEN-2 with high affinity GAG-binding phenotypes and to identify the molecular determinants for high affinity GAG binding of DEN-2, two virus strains, the mouse-passaged neurovirulent prototype strain, NGC (Meiklejohn et al., 1952) , and the natural isolate, PUO-218, were serially passaged five times in SW13 or BHK-21 cells. The same approach was employed previously for the selection of GAG-binding variants of JEV serotype flaviviruses and Tick-borne encephalitis virus (TBE) (Goto et al., 2003; Lee et al., 2004; Lee & Lobigs, 2002; Lobigs et al., 1990; Mandl et al., 2001) . Tissue culture supernatants were harvested after each passage between 4 and 6 days p.i., or when cpe was detectable. By the fifth passage, significant cpe was observed at 3 days p.i. in both BHK-21 and SW13 cells. Sequence analysis was performed on virion RNA extracts from uncloned as well as four plaque-purified virus stocks from each passage series. There was at least 1 nt change in the E protein gene of each passage variant, which resulted in a non-conservative amino acid change (Table 1) . Notably, the E protein changes in each of the passaged variants resulted in the net gain of positive charge consistent with enhanced GAG binding. The mutations appeared to be dominant in the fifth passage virus stocks, as sequence analysis of uncloned variant stocks did not show the parental sequence at the corresponding positions in the virus populations. BHK-21 cell-passaged PUO-218 comprised RLys 98 *Nucleotide changes in plaque-purified fifth passage virus are numbered from the 59 terminal nucleotide in the E protein gene (Gruenberg et al., 1988) . DAmino acid changes are numbered from the N-terminal residue in the E protein. , which showed a minor presence.
One of the key phenotypic changes associated with the adaptation of mosquito-and tick-borne flaviviruses to grow in SW13 and/or BHK-21 cells is the enhanced affinity of the passage variants for cell surface GAG relative to parental viruses (Goto et al., 2003; Lee et al., 2004; Lee & Lobigs, 2000 Mandl et al., 2001) . To investigate further the generality of altered virus-host receptor interaction(s) among the flaviviruses due to adaptation to the two cell lines, virus binding to heparin-Sepharose was measured. Heparin is a highly sulfated reference GAG. The PUO-218 strain did not show detectable binding to heparinSepharose beads, while SW13 and BHK-21 cell-passaged PUO-218 variants showed greater than 97 % binding (Table 1) . Interestingly, the parental DEN-2 NGC strain bound efficiently to heparin-Sepharose. Nevertheless, the binding of NGC R227 and NGC N249 was slightly increased relative to the parent (Table 1) .
Heparin-binding phenotypes of DEN-2 NGC and NGC/PUO-218 prM-E chimeric infectious cDNA clone-derived viruses with or without host cell adaptive mutations
To test the impact of single amino acid changes at PUO-218 strain E protein residues 120, 124 and 202 on heparinbinding affinity, the prM and E protein coding regions of PUO-218 with or without these host cell adaptive mutations were inserted into the full-length infectious cDNA clone of NGC (Gualano et al., 1998) ; the NGC/PUO-218 prM-E chimeric viruses are denoted rPUO, rPUO K120 , rPUO D124 and rPUO K202 . Virus rPUO closely resembled the PUO-218 strain in the lack of detectable binding to heparin-Sepharose (Fig. 1) . Viruses rPUO K120 and rPUO K202 , which differ from rPUO by the gain of a single positive charge in the E protein, showed >99 % binding to heparin-Sepharose. In contrast, the Asn 124 RAsp substitution in the E protein of rPUO E124 did not increase binding to heparin-Sepharose relative to that of rPUO. This mutation was selected in addition to the Glu 202 RLys change during passage of PUO-218 in BHK-21 cells.
Given the strong binding to heparin-Sepharose of NGC relative to the PUO-218 virus and the fact that the two strains show only one charge difference in the E protein at residue 126 (Lys/Glu) amongst a total of 8 aa differences in prM and E, it appeared likely that Lys at residue 126 accounted for the high GAG-binding affinity of NGC. To confirm this proposition, recombinant viruses rPUO K126 and rNGC E126 were generated. Virus rPUO K126 showed efficient binding to heparin-Sepharose (>95 %) comparable to that of rNGC, while the binding of rNGC E126 was markedly reduced (~15 %) relative to rNGC (Fig. 1) . Accordingly, Lys at E protein residue 126 is also a determinant of GAG affinity.
The already high GAG-binding affinity of NGC may obscure detection of further enhancement of GAG binding by other determinants. To corroborate that Arg at E protein residue 227, which was selected during passage of NGC in SW13 cells, is a major GAG-binding determinant, binding of rNGC E126 and rNGC E126/R227 to heparin-Sepharose was compared. The presence of a positive charge at residue 227 in variant rNGC E126/R227 significantly improved binding relative to rNGC E126 (Fig. 1) .
Effect of GAG-binding determinants on susceptibility of virus infectivity to heparin
We next investigated whether the DEN-2 GAG-binding determinants influenced dependence on cell surface GAG during virus entry. For this assay, only DEN-2 NGC and NGC/PUO-218 prM-E chimeric infectious clone-derived viruses were used. Virus and BHK-21 cells were preincubated with heparin at given concentrations followed by infection and quantification of infected cells by flowcytometry (Lee et al., 2006) . The infectivity of rNGC was reduced by more than 50 % at heparin concentrations of ¢2 mg ml 21 (Fig. 2a) , consistent with the previously determined 50 % effective concentration value of heparin for DEN-2 NGC using this assay (Lee et al., 2006 with rNGC at heparin concentrations between 2 and 200 mg ml 21 (Fig. 2a) .
The effect of host cell adaptive mutations in the E protein of rPUO on the susceptibility of virus infectivity to heparin was tested at a concentration of 200 mg ml 21 since there was negligible inhibition at 20 and 0?2 mg heparin ml 21 (data not shown). Virus rPUO showed 35 % inhibition of infectivity, whilst that of rPUO K120 and rPUO K202 was inhibited to a much greater extent (88 and 67 %, respectively; Fig. 2b) . Notably, rPUO D124 displayed reduced susceptibility to heparin inhibition relative to rPUO (Fig. 2b) , consistent with its lack of binding to heparin-Sepharose. Thus, the increase in negative charge on the viral surface of this variant appears to reduce further the relatively low GAG-binding affinity of PUO-218.
To investigate the role in attachment/entry of E protein residue 126, the susceptibility of infectivity to heparin inhibition of rNGC, rNGC E126 , rPUO and rPUO K126 was compared. The results show that the rNGC E126 and rPUO, and rPUO K126 and rNGC pairs are comparable in regard to their moderate and high susceptibility to heparin inhibition, respectively (Fig. 2b) , and confirm the importance of residue 126 as a GAG-binding determinant.
Influence of GAG-binding determinants on specific infectivity of DEN-2 for BHK-21, SW13 and Vero cells
The impact of E protein substitutions at GAG-binding sites on specific infectivity of DEN-2 for BHK-21, SW13 and Vero cells was examined using infectious clone-derived viruses collected over a 2 h period at 28 h p.i. The virus harvests were used for infectivity titration in Vero, BHK-21 and SW13 cells by TCID 50 assay and RNA quantification by RT-PCR (Lee et al., 2004) , and specific infectivity was determined as genome equivalent/TCID 50 ratio. Gain-ofpositive-charge mutations at E protein residues 120, 202, 227 and 249 increased infectivity for BHK-21 and SW13 cells by 10-to 170-fold, whereas that for Vero cells was comparable or slightly poorer (<10-fold) relative to the parental strains ( Table 2 ). The Asn 124 RAsp change, which contributed little to heparin binding (see above), resulted in a moderate enhancement (<10-fold) of specific infectivity for BHK-21 and SW13 cells, without markedly influencing the specific infectivity for Vero cells (Table 2 ).
The contribution of the GAG-binding determinant Lys 126
in the E protein of NGC to its significantly higher infectivity for BHK-21 cells relative to rPUO was examined. The specific infectivity of rPUO K126 for BHK-21 cells resembled that of rNGC, while that of rPUO and rNGC E126 was similar ( Table 2 ), suggesting that Lys 126 was mainly responsible for the high infectivity of NGC for BHK-21 cells. Notably, a similar effect of residue 126 on the specific infectivity for SW13 cells (compare rNGC and rPUO; Table 2 ) was not observed.
Mouse virulence of DEN-2 NGC and host cell-adapted variants
Natural isolates of DEN do not cause mortality or overt morbidity in adult immunocompetent mice by extraneural (Johnson & Roehrig, 1999) , as well as to natural DEN isolates when inoculated at a high dose i.v. route (Shresta et al., 2004) . To compare mouse virulence of NGC parent and passage variants, groups of 6-week-old IFN-a/c-R 2/2 mice were inoculated via the i.c. or i.p. route with 10 3 and 10 6 p.f.u., respectively. While the parental NGC virus caused 100 % mortality via both routes, NGC R227 was attenuated with no mortality observed by i.p. inoculation and significantly prolonged mean survival time (mst) relative to the parent following i.c. inoculation (Table 3a) . NGC N249 was partially attenuated by the i.p. route, showing reduced mortality and prolonged mst but was equally virulent by the i.c. infection route in comparison to the parental NGC virus (Table 3a ). All surviving mice were protected against i.p. challenge with 10 6 p.f.u. NGC given 4 weeks after primary infection, whilst challenged naïve IFN-a/c-R 2/2 mice at 10 weeks of age showed 100 % mortality (mst~18 days).
Mouse virulence of NGC and NGC-PUO-218 chimeric infectious clone-derived parent and GAG-binding variants
The impact of GAG-binding determinants on DEN virulence in IFN-a/c-R 2/2 mice was further examined using NGC and NGC/PUO-218 prM-E chimeric infectious clone-derived viruses (Table 3b) . Mice infected i.v. with 10 6 p.f.u. of rPUO showed 100 % mortality (mst= 12?6 days); rPUO D124 , which showed reduced susceptibility to heparin inhibition, was also uniformly lethal but slightly more virulent than rPUO according to the shorter mst. All GAG-binding variants except rPUO K202 were significantly attenuated relative to rPUO. Unexpectedly, the GAGbinding variant rPUO K202 gave 100 % mortality; however, with a significantly prolonged mst relative to rPUO. Interestingly, rNGC was less virulent than rPUO when inoculated by the i.v. route in IFN-a/c-R 2/2 mice (Table 3b ). This was surprising, given that the PUO-218 parental strain was not lethal for these mice when inoculated i.p. (10 6 p.f.u.) and only gave 20 % mortality when the same dose was inoculated i.v. (data not shown). Thus, it appears that the prM and E proteins of PUO-218 in combination with additional regions in the NGC polyprotein and/or non-coding regions of the NGC genome enhance neuroinvasiveness relative to the PUO-218 and NGC strains. Furthermore, we showed by i.c. inoculation of 10 3 p.f.u. that the neurovirulence of rNGC and rPUO was comparable in IFN-a/c-R 2/2 mice: both strains gave 100 % mortality with mst of 8?0 and 8?8 days, respectively (Table 3b ). The conflicting virulence profiles of rNGC and rPUO in IFN-a/ c-R 2/2 mice may be attributed to their differential capacity to spread in extraneural tissues and, in turn, be a consequence of the differential GAG-binding properties of the two viruses. This hypothesis is further supported by virulence data for the rPUO K126 and rNGC E126 pair: mortality Table 3 . Virulence in IFN-a/c-R "/" mice Virus Mortality (%; P value*) Mst (days)±SD (P value*) Mortality (%; P value) Mst (days)±SD (P value) NT NT NT, Not tested. *Statistical analysis was performed in pairwise comparison relative to NGC strain in (a) and rPUO strain in (b) on mst values using the MannWhitney U test and on mortality values using the Fisher's exact test; differences considered significant (P¡0?05) are in bold.
for the strongly GAG-binding virus, rPUO K126 , following i.v. infection was significantly reduced relative to rPUO, whilst it was slightly increased for rNGC E126 , which binds poorly to GAG, relative to rNGC. Notably, groups of mice infected with rNGC E126 showed significantly reduced mst relative to rNGC (15?3 versus 24?5 days; P=0?0004).
In addition to being a determinant of GAG-affinity and neuroinvasiveness, residue 126 also influences mouse neurovirulence (Gualano et al., 1998) , since new-born BALB/c mice inoculated i.c. with the 10 3 p.f.u. of rNGC or rNGC
E126
showed mortality of 100 and 80 % and significantly different mst of 7?4 and 10?4 days, respectively (P=0?008), while mice similarly infected with rPUO or rPUO K126 showed mortality of 0 and 100 % (mst of 8 days) (our unpublished results, which confirm those of Gualano et al., 1998) . The neurovirulence phenotype mediated by the presence of a positive charge at residue 126 is unlikely to be due to increased GAG affinity because other GAG-binding variants (rPUO K120 and rPUO D124/K202 ) did not show greater mouse neurovirulence than rPUO when tested similarly (data not shown).
Rapid clearance of DEN-2 GAG-binding variants from the circulation
Our mouse virulence data showed a remarkably consistent correlation between GAG-binding affinity of DEN-2 viruses and virulence attenuation in IFN-a/c-R 2/2 mice following inoculation by an extraneural route. This raised the possibility that virulence attenuation resulted from the rapid clearance of GAG-binding variants from the circulation by non-productive binding to surfaces enriched in GAG, as has been demonstrated for JEV serogroup flaviviruses (Lee et al., 2004; Lee & Lobigs, 2002) . To test this possibility, virus titres in serum samples collected over a 30 min period from mice inoculated, i.v., with a high dose of rPUO or rPUO K120 was determined. The rPUO virus titres did not show significant reduction over 30 min, while rPUO K120 showed ¢2 log reduction in serum titres over the same period (Fig. 3) .
Predicted location of GAG-binding determinants on the DEN-2 E protein structure
The GAG-binding determinants, 120, 126, 202, 227 and 249 , are located at sites that are highly conserved between DEN-2 isolates. When plotted on an alignment of E protein sequences from 33 DEN-2 isolates (Lewis et al., 1993) representing five subtypes and isolated between 1944 and 1990, only substitutions that gave rise to an increase in positive charge were found in a small number of isolates at these residues, with most isolates displaying the low GAG-binding determinant. When mapped onto the crystal structure of DEN-2 E protein (Modis et al., 2003), residues 120, 126, 202, 227 and 249, without exception, cluster in the central region of the E protein dimer and are exposed on the upper face of domain II (Fig. 4) .
DISCUSSION
This study describes five GAG-binding determinants on the E protein of DEN-2; four of these (residues 120, 202, 227 and 249) were identified as host cell adaptive mutations involving the acquisition of increased net positive charge on the viral surface, while one (residue 126) was found to be present in the mouse brain-adapted NGC strain, which is mouse neurovirulent and an early DEN-2 vaccine candidate along with other mouse brain-adapted DEN viruses (Meiklejohn et al., 1952; Sabin, 1952 Sabin, , 1955 Sabin & Schlesinger, 1945; Schlesinger et al., 1956) . Consistent with recent studies by us and others on the encephalitic flaviviruses MVE, JEV, WNV and TBE, GAG-binding variants selected by serial passage of DEN-2 in BHK-21 and/or SW13 cells displayed reduced mouse virulence by peripheral infection routes (Goto et al., 2003; Lee et al., 2004; Lee & Lobigs, 2000 Mandl et al., 2001) . Accordingly, flaviviruses appear to universally engage with high affinity to cell surface GAG for efficient attachment/entry of some cell types, an adaptation that is detrimental for virus spread in the animal host.
The altered host cell tropism of DEN-2 GAG-binding variants was confirmed by specific infectivity determinations: gain-of-positive-charge mutations at E protein residues 120, 202, 227 and 249 significantly increased infectivity for BHK-21 and SW13 cells, whereas that for Vero cells was comparable or slightly poorer relative to the parental strains. Thus, distinct cell surface receptors appear to be involved in attachment/entry of DEN-2 during infection of Vero, BHK-21 and SW13 cells; the contribution of virus binding to GAG seems to be minimal for the efficient infection of Vero cells but is beneficial for that of BHK-21 and SW13 cells. The GAG-binding determinant at E protein residue 126 differed from the others in that a Lys at this residue markedly enhanced the specific infectivity for BHK-21 but not for SW13 cells. This may underscore the influence of the large structural diversity of cell surface GAG (Bernfield et al., 1999) on the specificity of virus-host cell interaction. Given that specific quantitative and qualitative changes in expression of cell surface GAG are a hallmark of metastatic carcinoma cells (Sasisekharan et al., 2002) , it is possible that the marked change in cell tropism of DEN-2 and other flaviviruses selected for growth in SW13 cells (adrenal gland small cell carcinoma) relates to a characteristic cell surface GAG phenotype associated with malignant transformation. This raises the question whether the selective incorporation of GAG-binding determinants can improve the effectiveness of oncolytic viruses for clinical application.
The location of DEN-2 GAG-binding determinants on the E protein crystal structure was of interest, in particular in comparison to that of other flaviviruses belonging to different serocomplexes. Remarkably, residues 120, 126, 202, 227 and 249 are exclusively clustered on the exposed surface of domain II in the centre of the E protein dimer (Modis et al., 2003 (Modis et al., , 2005 . This contrasts with the location of key GAG-binding determinants of the JEV serotype flaviviruses in two clusters on domain III (residues 306 and 389/390) and domain I (residues 59 and 138) (Lee et al., 2004; Lee & Lobigs, 2000 , whilst adaptation of TBE to BHK-21 cells selected for GAG-binding variants altered at residues distributed throughout the upper surface across all three structural domains (Mandl et al., 2001) . It was surprising that none of the DEN-2 GAG-binding determinants were localized to E protein domain III, given that this part of the protein is thought to function in receptor binding (Lobigs et al., 1990; Rey et al., 1995) and that the attachment of a soluble DEN-2 domain III to BHK-21 cells could be blocked by heparin (Hung et al., 2004) . Comparative analysis of the crystal structures of DEN-2 and -3 E protein ectodomains identified two clusters of positively charged residues predicted to function in GAG binding, one in domain I and a second in domain II, but could not confirm the existence of GAG-binding residues in domain III (Modis et al., 2005) . The GAG-binding determinants identified here cluster with the putative GAG-binding residues in domain II (Modis et al., 2005) , suggesting that the host cell adaptive changes enhance affinity of an existing GAGbinding site in the DEN E protein. Collectively, the spatial distribution of GAG-binding residues on the E protein from the different flaviviruses implies that multiple regions on the E proteins surface can engage with host cell receptors for virus attachment/entry, which is not inconsistent with the flat, elongated architecture of the E protein dimer.
We and others have reported that among the encephalitic flaviviruses an increase in GAG-binding affinity invariably gives rise to virulence attenuation (Goto et al., 2003; Lee et al., 2004; Lee & Lobigs, 2000 Mandl et al., 2001 ) by a mechanism of rapid clearance of virus from the circulation (Lee et al., 2004; Lee & Lobigs, 2002) . Here, we show that this principle also applies to DEN encephalitis in mice. Although human DEN infection gives rise primarily to a febrile illness with arthralgia and occasional haemorrhagic manifestation, which cannot be reproduced in laboratory animals, the IFNa/c-R 2/2 mouse model used in this study is pertinent to the understanding of DEN virulence in primates, where a reduction in viraemia titre and duration is considered the best marker of attenuation of DEN vaccine candidates (Saluzzo, 2003) . In our mouse model, mortality as the result of encephalitis following virus inoculation by an extraneural route was used as virulence read-out and largely reflects the ability of a virus strain to produce viraemia of sufficient magnitude and/or duration to cross the blood-brain barrier.
A defect in the interferon responses was required for this to occur in adult mice. Therefore, the conclusions drawn here from studies in mice on the attenuation of DEN-2 GAGbinding variants most likely also apply to their pathogenicity in humans. Notably, DEN-2 vaccine candidates NGC and PR-159-S1 (Eckels et al., 1976 Meiklejohn et al., 1952; Sabin, 1955; Scott et al., 1980) produced by serial passage in mouse brain and primary green monkey kidney cells display acidic to basic amino acid substitutions at GAG-binding determinants 126 (Gualano et al., 1998) and 202 (Hahn et al., 1988) , respectively. We hypothesize that the mechanism of attenuation of these candidate DEN vaccines involves a defect in the ability of the viruses to spread in the infected host via the reticuloendothelial system due to high affinity GAG interaction.
Repeated mouse brain passage of DEN and Yellow fever virus (YFV), which are not neurotropic in natural infections, yields variants that are attenuated in viscerotropism in humans and monkeys but have acquired high neurovirulence in mice (reviewed by Burke & Monath, 2001 ). For DEN-2 NGC, a GluRLys mutation at E protein residue 126 was implicated as a major determinant of mouse neurovirulence (Bray et al., 1998; Gualano et al., 1998) . Notably, a YFV-DEN-2 chimera with the prM-E of PUO-218 is far less neurovirulent and replicates poorly in the brain relative to the YFV 17D vaccine and a YFV-DEN-4 chimera with the prM-E of a neurovirulent DEN-4 strain (Chambers et al., 2003) . Taken together with our investigation showing that Lys 126 is a GAG-binding determinant which attenuates neuroinvasiveness, it is apparent that a single mutation can reduce disease in extraneural tissues (viscerotropism) as well as increase neurovirulence.
Given that cell-to-cell spread in neurons is a route for virus dissemination in the central nervous system, it is not unexpected that the influence of GAG affinity on virulence can differ in virus infections of the brain and in extraneural tissues. Indeed, the greater neurovirulence associated with DEN-2 NGC as a consequence of Lys 126 relative to variants with low GAG-binding affinity suggests that the efficiency of interaction between the virus and GAG on the surface of neuronal cells contributes to virus pathogenicity in the brain. A correlation between high GAG-binding affinity of strains of Murine leukemia virus (Jinno-Oue et al., 2001), Theiler's murine encephalomyelitis virus (Reddi et al., 2004) and high neurovirulence has also been reported. With regard to the neurotropism of DEN-2 NGC in comparison to that of non-brain-adapted strains (e.g. PUO-218), we find that the prM and E proteins of the latter (when incorporated into the NGC infectious clone; rPUO) confer comparable neurovirulence in IFN-a/c-R 2/2 mice. However, this is not the case in i.c. infection of new-born mice where rPUO is attenuated but NGC and rPUO K126 are both virulent (Gualano et al., 1998) . This raises the possibility that Lys
